AI is reengineering drug discovery by speeding up testing and scanning petabytes of data for connections between diseases

AI is reshaping biomedical research and drug discovery and delivery. But challenges still exist.

By: Jeffrey Skolnick, Georgia Institute of Technology and Benjamin P. Brown, Vanderbilt University, The Conversation

Outlets: The Conversation

Published: April 7, 2026

Words: 1,369

Last Updated: 3 months, 3 weeks ago

Body Text Preview

By Jeffrey Skolnick, Georgia Institute of Technology and Benjamin P. Brown, Vanderbilt University

In December, The Conversation hosted a webinar on AI’s revolutionary role in drug discovery and development.

Science and technology editor Eric Smalley interviewed Jeffrey Skolnick, eminent scholar in computational systems biology at Georgia Institute of Technology, and Benjamin P. Brown, assistant professor of pharmacology at Vanderbilt University.

Skolnick has developed AI-based approaches to predict protein structure and function that may …

Create a free account to access this story and more

Join Plucky Wire to access full stories, collaborate with newsrooms, and discover content from networks around the world.
Register for Free Log in